UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): (September 28, 2006) September 25, 2006
Momenta Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware |
|
000-50797 |
|
04-3561634 |
|
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
675 West Kendall Street, Cambridge, MA |
|
|
|
02142 |
|
(Address of Principal Executive Offices) |
|
|
|
(Zip Code) |
(617)
491-9700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On September 25, 2006, Momenta Pharmaceuticals, Inc. (the “Company”), granted Peter Barton Hutt, a member of the Company’s Board of Directors, nonstatutory stock options (the “Options”) to purchase 6,500 shares of the Company’s Common Stock as compensation under the amendment dated September 18, 2006 to Mr. Hutt’s consulting agreement with the Company dated September 18, 2002, as amended by September 29, 2003, October 4, 2004 and September 22, 2005 agreements. The Options have an exercise price of $12.81 per share, have a three-year duration and vest in 12 equal, monthly installments, with the first installment vesting one month from the date of grant. The Options were issued under the Company’s 2004 Stock Incentive Plan, as amended, pursuant to the terms and conditions of the Form of Nonstatutory Stock Option Agreement under such Plan. The Form of Nonstatutory Stock Option Agreement was filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
10.1 |
|
Form of Nonstatutory Stock Option Agreement (Filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004, Commission File No. 0-50797, is incorporated herein by reference). |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MOMENTA PHARMACEUTICALS, INC. |
||
|
|
|
|
|
|
Date: September 28, 2006 |
|
By: |
/s/ Craig A. Wheeler |
|
|
|
|
Craig A. Wheeler |
3